Timothy Chiang
Stock Analyst at Capital One
(1.13)
# 3,819
Out of 5,117 analysts
5
Total ratings
20%
Success rate
0.97%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Timothy Chiang
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ANIP ANI Pharmaceuticals | Initiates: Overweight | n/a | $82.40 | - | 1 | Mar 15, 2024 | |
| PTGX Protagonist Therapeutics | Initiates: Buy | $55 | $88.78 | -38.05% | 2 | Feb 11, 2022 | |
| AMPH Amphastar Pharmaceuticals | Upgrades: Outperform | n/a | $27.12 | - | 1 | Oct 5, 2020 | |
| IDYA IDEAYA Biosciences | Initiates: Outperform | $28 | $35.18 | -20.41% | 1 | Sep 1, 2020 |
ANI Pharmaceuticals
Mar 15, 2024
Initiates: Overweight
Price Target: n/a
Current: $82.40
Upside: -
Protagonist Therapeutics
Feb 11, 2022
Initiates: Buy
Price Target: $55
Current: $88.78
Upside: -38.05%
Amphastar Pharmaceuticals
Oct 5, 2020
Upgrades: Outperform
Price Target: n/a
Current: $27.12
Upside: -
IDEAYA Biosciences
Sep 1, 2020
Initiates: Outperform
Price Target: $28
Current: $35.18
Upside: -20.41%